Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis

被引:72
作者
Defontaine, A
Zouhair, R
Cimon, B
Carrère, J
Bailly, E
Symoens, F
Diouri, M
Hallet, JN
Bouchara, JP
机构
[1] CNRS, FRE 2230, Fac Sci, Lab Biotechnol,Unite Biocatalyse, F-44072 Nantes 03, France
[2] Ctr Hosp Univ, Lab Parasitol Mycol, UPRES EA 3142, Grp Etud Interact Hote Parasite, Angers, France
[3] Hop Renee Sabran, Biol Lab, Giens, France
[4] Ctr Hosp Univ, Serv Parasitol Mycol, Tours, France
[5] Inst Sci Sante Publ Louis Pasteur, Sect Mycol, Brussels, Belgium
[6] Univ Moulay Ismail, Fac Sci, Dept Biol, Meknes, Morocco
关键词
D O I
10.1128/JCM.40.6.2108-2114.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Usually a saprophyte, Scedosporium apiospermum often colonizes the respiratory tracts of patients with cystic fibrosis (CF). In order to improve our understanding of the molecular epidemiology of the airway colonization, 129 sequential and multiple isolates collected from January 1998 to March 1999 from nine CF patients monitored in three hospitals in France were typed by random amplification of polymorphic DNA with primers GC70, UBC-701, and UBC-703. Among these primers, UBC-703 was the most discriminating, allowing the differentiation of 14 genotypes. Combining the results obtained with this three-primer set resulted in the differentiation of 16 genotypes. No common genotype was found among the different patients, and no clustering according to geographic origin of the isolates was seen. In addition, five of the patients were colonized by a single genotype. The others usually exhibited a predominant genotype accompanied by one or two others, which were found occasionally and were genetically close to the predominant genotype. Thus, our study demonstrates the persistence of the fungus despite antifungal treatments and therefore reinforces the need for the development of new antifungals that are more efficient against this species.
引用
收藏
页码:2108 / 2114
页数:7
相关论文
共 26 条
  • [21] Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii):: An emerging mycosis
    Tadros, TS
    Workowski, KA
    Siegel, RJ
    Hunter, S
    Schwartz, DA
    [J]. HUMAN PATHOLOGY, 1998, 29 (11) : 1266 - 1272
  • [22] CLINICAL-SIGNIFICANCE OF PSEUDALLESCHERIA-BOYDII - A REVIEW OF 10 YEARS EXPERIENCE
    TRAVIS, LB
    ROBERTS, GD
    WILSON, WR
    [J]. MAYO CLINIC PROCEEDINGS, 1985, 60 (08) : 531 - 537
  • [23] Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis
    Verweij, PE
    Meis, JFGM
    Sarfati, J
    HoogkampKorstanje, JAA
    Latge, JP
    Melchers, WJG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) : 2595 - 2597
  • [24] PCR-based identification of clinically relevant Pseudallescheria/Scedosporium strains
    Wedde, M
    Muller, D
    Tintelnot, K
    De Hoog, GS
    Stahl, U
    [J]. MEDICAL MYCOLOGY, 1998, 36 (02) : 61 - 67
  • [25] Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease
    Williamson, ECM
    Speers, D
    Arthur, IH
    Harnett, G
    Ryan, G
    Inglis, TJJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) : 47 - 50
  • [26] Typing of Scedosporium apiospermum by multilocus enzyme electrophoresis and random amplification of polymorphic DNA
    Zouhair, R
    Defontaine, A
    Ollivier, C
    Cimon, B
    Symoens, F
    Hallet, JN
    Deunff, J
    Bouchara, JP
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 50 (10) : 925 - 932